677304-78-8

Basic information

• Product Name: 5-Bromo-benzo[d]isothiazole-3-carboxylic acid
• Synonyms: 5-BROMO-BENZO[D]ISOTHIAZOLE-3-CARBOXYLIC ACID;5-BROMO-1,2-BENZISOTHIAZOLE-3-CARBOXYLIC ACID
• CAS NO: 677304-78-8
• Molecular Formula: C8H4BrNO2S
• Molecular Weight: 258.09
• Mol File: 677304-78-8.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 337.5 °C at 760 mmHg
• Flash Point: 157.9 °C
• Appearance: /
• Density: 1.912 g/cm³
• Vapor Pressure: 4.09E-05mmHg at 25°C
• Refractive Index: 1.753
• Storage Temp.: 2-8°C
• PKA: 4.52±0.50(Predicted)
• CAS DataBase Reference: 5-Bromo-benzo[d]isothiazole-3-carboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 5-Bromo-benzo[d]isothiazole-3-carboxylic acid(677304-78-8)
• EPA Substance Registry System: 5-Bromo-benzo[d]isothiazole-3-carboxylic acid(677304-78-8)

Safety Data

• Hazardous Substances Data: 677304-78-8(Hazardous Substances Data)

Usage

General Description

5-Bromo-benzo[d]isothiazole-3-carboxylic acid is a chemical compound with the molecular formula C9H5BrNOS. It is a heterocyclic compound containing a benzene ring fused to an isothiazole ring with a carboxylic acid group attached at position 3. 5-Bromo-benzo[d]isothiazole-3-carboxylic acid is commonly used in the pharmaceutical industry as a building block for the synthesis of various bioactive molecules and pharmaceutical drugs. It has also been studied for its potential antimicrobial and anticancer properties. The presence of the bromine atom in its structure makes 5-Bromo-benzo[d]isothiazole-3-carboxylic acid a useful intermediate in the synthesis of complex organic molecules and pharmaceutical compounds.

InChI:InChI=1/C8H4BrNO2S/c9-4-1-2-6-5(3-4)7(8(11)12)10-13-6/h1-3H,(H,11,12)

Upstream product

• 40991-34-2 1,2-benzisothiazole-3-carboxylic acid 

Downstream Products

• 936923-58-9 ethyl 5-bromo-benzo[d]isothiazole-3-carboxylate 

Relevant articles and documents

NOVEL SUBSTITUTED PYRIDO-PIPERAZINONE DERIVATIVES AS GAMMA SECRETASE MODULATORS

The present invention is concerned with novel substituted pyrido-piperazinone derivatives of Formula (I) wherein R1, R2, R3, R4, R5, L, Z and X have the meaning defined in the claims. The compounds according to the present invention are useful as gamma secretase modulators. The invention further relates to processes for preparing such novel compounds, pharmaceutical compositions comprising said compounds as an active ingredient as well as the use of said compounds as a medicament.

Synthesis and SAR of benzisothiazole- and indolizine-β-D- glucopyranoside inhibitors of SGLT2

A series of benzisothiazole- and indolizine-β-d-glucopyranoside inhibitors of human SGLT2 are described. The synthesis of the C-linked heterocyclic glucosides took advantage of a palladium-catalyzed cross-coupling reaction between a glucal boronate and the corresponding bromo heterocycle. The compounds have been evaluated for their human SGLT2 inhibition potential using cell-based functional transporter assays, and their structure-activity relationships have been described. Benzisothiazole-C-glucoside 16d was found to be an inhibitor of SGLT2 with an IC50 of 10 nM.

Indoles, 1h-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereof

The present invention relates generally to the field of ligands for nicotinic acetylcholine receptors (nACh receptors), activation of nACh receptors, and the treatment of disease conditions associated with defective or malfunctioning nicotinic acetylcholine receptors, especially of the brain. Further, this invention relates to novel compounds (indazoles and benzothiazoles), which act as ligands for the α7 nACh receptor subtype, methods of preparing such compounds, compositions containing such compounds, and methods of use thereof.